S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.96 (+0.20%)
T   16.28 (+0.99%)
F   12.03 (-0.08%)
MU   112.27 (-3.49%)
GE   153.80 (-1.20%)
CGC   8.06 (+24.19%)
DIS   112.87 (-0.06%)
AMC   2.93 (-1.68%)
PFE   25.35 (-0.28%)
PYPL   62.25 (-1.60%)
XOM   118.51 (-0.10%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ANA Holdings Inc. stock logo
ALNPY
ANA
$3.85
-6.3%
$4.23
$3.76
$4.93
N/A0.51,117 shs1,160 shs
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
$9.85
+5.5%
$9.85
$5.70
$10.90
$11.34B0.952,876 shs3,900 shs
Edenred SE stock logo
EDNMY
Edenred
$23.50
-0.8%
$26.82
$23.25
$34.35
$11.73B0.7611,788 shs10,982 shs
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
$25.08
-1.0%
$27.75
$23.31
$31.36
$14.71B0.4431,687 shs38,676 shs
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
$0.38
$0.36
$0.32
$0.56
$7.20B0.45338 shsN/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ANA Holdings Inc. stock logo
ALNPY
ANA
-6.21%-6.89%-11.19%-9.84%-7.89%
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
0.00%0.00%0.00%0.00%0.00%
Edenred SE stock logo
EDNMY
Edenred
-0.84%-5.05%-12.15%-25.98%-25.40%
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
-0.95%-9.88%-10.20%-16.27%+2.08%
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
0.00%+4.59%+5.63%-7.91%-31.64%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ANA Holdings Inc. stock logo
ALNPY
ANA
N/AN/AN/AN/AN/AN/AN/AN/A
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
N/AN/AN/AN/AN/AN/AN/AN/A
Edenred SE stock logo
EDNMY
Edenred
N/AN/AN/AN/AN/AN/AN/AN/A
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
N/AN/AN/AN/AN/AN/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ANA Holdings Inc. stock logo
ALNPY
ANA
3.00
BuyN/AN/A
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
N/AN/AN/AN/A
Edenred SE stock logo
EDNMY
Edenred
3.00
BuyN/AN/A
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
N/AN/AN/AN/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ANA Holdings Inc. stock logo
ALNPY
ANA
$12.64BN/A$0.03 per share127.69N/AN/A
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
$2.06B5.50$0.33 per share29.85$2.33 per share4.23
Edenred SE stock logo
EDNMY
Edenred
$2.50B4.69$1.15 per share20.41($1.29) per share-18.22
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
$5.12B2.84$1.50 per share16.73$5.02 per share5.00
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ANA Holdings Inc. stock logo
ALNPY
ANA
$662.13M$0.488.02N/A8.73%18.17%4.89%N/A
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
$345.41M$0.2637.8839.40N/AN/AN/AN/AN/A
Edenred SE stock logo
EDNMY
Edenred
$288.95MN/A0.0017.940.85N/AN/AN/AN/A
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
$564.67M$0.9925.3323.66N/A11.33%20.58%9.62%N/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/A0.00N/AN/AN/AN/AN/A

Latest ALNPY, DVDCY, EDNMY, SBMFF, and NRILY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
1/31/2024Q3 2024
ANA Holdings Inc. stock logo
ALNPY
ANA
N/A$0.14+$0.14$0.14N/A$3.66 billion
1/31/2024Q3 2024
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
N/A$0.27+$0.27$0.27N/A$1.27 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ANA Holdings Inc. stock logo
ALNPY
ANA
N/AN/AN/AN/AN/A
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
$0.040.41%N/A15.38%N/A
Edenred SE stock logo
EDNMY
Edenred
$0.401.70%N/AN/AN/A
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
$0.220.88%N/A22.22%N/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ANA Holdings Inc. stock logo
ALNPY
ANA
1.28
1.71
1.65
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
0.15
1.49
0.95
Edenred SE stock logo
EDNMY
Edenred
N/AN/AN/A
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
0.57
1.61
N/A
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ANA Holdings Inc. stock logo
ALNPY
ANA
40,507N/AN/ANot Optionable
Davide Campari-Milano S.p.A. stock logo
DVDCY
Davide Campari-Milano
3,7011.15 billionN/ANot Optionable
Edenred SE stock logo
EDNMY
Edenred
10,000499.18 millionN/ANot Optionable
Nomura Research Institute, Ltd. stock logo
NRILY
Nomura Research Institute
6,782580.80 million225.93 millionNot Optionable
Sino Biopharmaceutical Limited stock logo
SBMFF
Sino Biopharmaceutical
26,07918.81 billionN/ANot Optionable

ALNPY, DVDCY, EDNMY, SBMFF, and NRILY Headlines

SourceHeadline
Sino Biopharm, Boehringer partner on oncology assets in ChinaSino Biopharm, Boehringer partner on oncology assets in China
bioworld.com - April 11 at 12:04 AM
Sino Biopharm and Boehringer Ingelheim enter into strategic collaborationSino Biopharm and Boehringer Ingelheim enter into strategic collaboration
chinadaily.com.cn - April 10 at 7:03 PM
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mlnSino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
reuters.com - February 6 at 11:33 PM
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 millionSino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 million
news.yahoo.com - February 6 at 11:33 PM
Sino Biopharmaceutical Ltd.Sino Biopharmaceutical Ltd.
wsj.com - January 30 at 9:44 PM
Jefferies Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)Jefferies Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
markets.businessinsider.com - December 29 at 11:14 PM
Birminghams Ahmad Al Sino jailed for relatives wedding row murderBirmingham's Ahmad Al Sino jailed for relative's wedding row murder
bbc.co.uk - December 15 at 12:52 PM
Hong Kong Shares Turn Higher as Lower Oil Prices, Treasury Yields SupportHong Kong Shares Turn Higher as Lower Oil Prices, Treasury Yields Support
finance.yahoo.com - November 7 at 9:54 PM
Sino Biological opens Texas bioprocessing centerSino Biological opens Texas bioprocessing center
bioprocessintl.com - October 20 at 8:34 AM
Insights into Sino Biopharmaceutical Ltds Dividend PerformanceInsights into Sino Biopharmaceutical Ltd's Dividend Performance
finance.yahoo.com - October 4 at 9:05 AM
Sino Logistics Corporation PCL (SINO)Sino Logistics Corporation PCL (SINO)
uk.investing.com - September 29 at 6:54 PM
Sino Biopharmaceutical LtdSino Biopharmaceutical Ltd
jp.reuters.com - September 13 at 10:52 PM
Sino-Pak joint annual air exercise Shaheen-X begins in ChinaSino-Pak joint annual air exercise Shaheen-X begins in China
radio.gov.pk - September 13 at 10:52 PM
Patch-up plan fails; drawn-out Sino-Japan feud now expectedPatch-up plan fails; drawn-out Sino-Japan feud now expected
asahi.com - September 8 at 4:21 PM
Sino Biopharmaceutical Ltd ADR (SBHMY)Sino Biopharmaceutical Ltd ADR (SBHMY)
investing.com - July 17 at 12:55 AM
Sino Biopharm acquires obesity treatment from Gmax in $57M dealSino Biopharm acquires obesity treatment from Gmax in $57M deal
bioworld.com - June 16 at 10:05 AM
The Sino-Indian RivalryThe Sino-Indian Rivalry
cambridge.org - June 15 at 12:44 PM
Sino-ForestSino-Forest
forbes.com - May 30 at 9:14 PM
THAAD and the Sino-South Korean Strategic DilemmaTHAAD and the Sino-South Korean Strategic Dilemma
thediplomat.com - May 25 at 10:16 AM
Is a Sino-US War Inevitable?Is a Sino-US War Inevitable?
thediplomat.com - May 19 at 4:26 PM
Cantosino.com (SINO) MarketsCantosino.com (SINO) Markets
fxempire.com - March 26 at 7:17 PM
Sino Biopharmaceutical Limited (1177.HK)Sino Biopharmaceutical Limited (1177.HK)
finance.yahoo.com - March 12 at 7:29 AM
Sino Biopharm continues global growthSino Biopharm continues global growth
global.chinadaily.com.cn - March 9 at 7:12 PM
Sino Biopharm Wins CFIUS Approval for $161 Million F-Star DealSino Biopharm Wins CFIUS Approval for $161 Million F-Star Deal
msn.com - March 7 at 6:57 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

ANA logo

ANA

OTCMKTS:ALNPY
ANA Holdings Inc., together with its subsidiaries, provides air transportation services in Japan and internationally. It operates through Air Transportation, Aviation-Related Business, Travel Business, and Trading Business segments. The Air Transportation segment offers regular and irregular air transport of passengers, cargo, etc. on domestic and international routes. The Aviation-Related Business segment provides services incidental to air transportation, such as airport handling and maintenance. The Travel Business develops and sells travel products, as well as plans and sells package travel products. The Trading Business imports and exports aviation-related materials, as well as sells through stores and mail-order channels. The company was formerly known as All Nippon Airways Co., Ltd. and changed its name to ANA Holdings Inc. in April 2013. ANA Holdings Inc. was incorporated in 1920 and is headquartered in Minato, Japan.
Davide Campari-Milano logo

Davide Campari-Milano

OTCMKTS:DVDCY
Davide Campari-Milano S.p.A., together with its subsidiaries, manufactures and trades in alcoholic and non-alcoholic beverages in the Americas, Europe, the Middle East, Africa, Europe, and the Asia-Pacific. Its product portfolio includes aperitifs, vodka, whisky, tequila, rum, gin, liqueurs, sparkling and still wines, and ready to drink products under approximately 50 brands. The company was founded in 1860 and is headquartered in Sesto San Giovanni, Italy. Davide Campari-Milano S.p.A. is a subsidiary of Alicros S.p.A.
Edenred logo

Edenred

OTCMKTS:EDNMY
Edenred SE provides digital platform for services and payments for companies, employees, and merchants worldwide. It offers employee benefit solutions, including Ticket Restaurant, a solution that allows employees to take time out for lunch at a partner merchant; Ticket Alimentación that allows users to pay for groceries in neighborhood stores and supermarkets; Ticket Regalo, a gift voucher; Ticket CESU, a human services solution; Ticket Plus Card, a solution that enables the purchase of staples, such as food and fuel; Ticket Welfare, which employees can use to pay for a range of services, such as access to sports facilities and solutions for their children's educational needs; Ticket Guardería for companies without on-site daycare facilities; Childcare Vouchers; Ticket EcoCheque, a solutions that encourages purchase of environmentally friendly products; Ticket Kadeos Culture and Ticket Cultura that are solutions for cultural goods and services. The company also offers mobility solutions comprising Ticket Log for light vehicle fleet management; Ticket Fleet Pro and Ticket Cargo for truck fleet management; Ticket Car for employees to pay for fuel and other business travel expenses; UTA Edenred for paying tolls, optimize routes, pay for roadside assistance and truck servicing, and for VAT reimbursement; fuel cards; and refund services for VAT and excise duties. In addition, it provides complementary solutions comprising corporate payment, invoice processing automation, and salary card solutions. Edenred SE was founded in 1962 and is headquartered in Issy-les-Moulineaux, France.
Nomura Research Institute logo

Nomura Research Institute

OTCMKTS:NRILY
Nomura Research Institute, Ltd. provides consulting, financial information technology (IT) solution, industrial IT solution, and IT platform services in Japan and internationally. Its Consulting segment offers management, operational, and system consulting services for enterprises and government agencies. This segment also offers research, future projections, and recommendations to society, economics, business, technology, etc. The company's Financial IT Solutions segment provides system consulting, development, and management solutions, as well as shared online and BPO services for the financial institutions, including the securities, insurance, banking, asset management, and other financial sectors. Its Industrial IT Solutions segment offers system consulting, development, and management solutions, as well as shared online services primarily for the distribution, manufacturing, service, and public sectors. The company's IT Platform Services segment engages in the data center operation activities and construction of IT platforms and networks to the Financial IT and Industrial IT Solutions segments, as well as provides IT platform solutions and information security services to external clients. This segment is also involved in the research related to advance IT, etc. The company was founded in 1965 and is headquartered in Tokyo, Japan.
Sino Biopharmaceutical logo

Sino Biopharmaceutical

OTCMKTS:SBMFF
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.